Alterity Therapeutics Limited
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Alterity Therapeutics Limited now
Current reporting with the operating signal separated from the noise.
Kalkine Media
Why Is Alterity Therapeutics Limited (ASX:ATH) in Focus Across ASX Healthcare Stocks Today?
Investors are testing whether Alterity Therapeutics Limited’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest ATHE filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
6-KOfficial SEC filingFiled 2026-09-23 · Period 2026-09-30SEC ↗6-KOfficial SEC filingFiled 2026-09-18 · Period 2026-09-30SEC ↗S-8Official SEC filingFiled 2026-09-18SEC ↗6-KOfficial SEC filingFiled 2026-09-16 · Period 2026-09-30SEC ↗4Official SEC filingFiled 2026-09-08 · Period 2026-08-31SEC ↗4Official SEC filingFiled 2026-09-08 · Period 2026-08-31SEC ↗6-KOfficial SEC filingFiled 2026-09-08 · Period 2026-09-30SEC ↗6-KOfficial SEC filingFiled 2026-09-08 · Period 2026-09-30SEC ↗
Alterity Therapeutics Limited, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →